Brigatinib Vs Crizotinib in ALK TKI-naive ALK+ NSCLC: Final Results from ALTA-1L
S. Popat,H. R. Kim,M-J. Ahn,J. C. Yang,J-Y. Han,M. J. Hochmair,K. H. Lee,A. Delmonte,M. R. Garcia Campelo,D-W. Kim,F. Griesinger,E. Felip,R. Califano,A. Spira,S. N. Gettinger,M. Tiseo,H. M. Lin,Y. Liu,F. Vranceanu,D. R. Camidge Lung cancer(2022)
AI 理解论文
溯源树
样例